Canmab Trastuzumab 440mg Injection

Canmab Trastuzumab 440mg Injection
Canmab Trastuzumab 440mg Injection
Price And Quantity
  • 1
  • Unit/Units
  • 35000 INR
Product Specifications
  • Drug Solutions
  • Trastuzumab 440mg
  • Liquid
  • Anti-Cancer
  • Breast cancer or stomach cancer
  • As directed by physician
  • As guided by physician
  • Store at 2C to 8C
    Product Description

    440 mg of canmab-trastuzumab Some cancer kinds are treated with an injection of a drug. Its main component, Trastuzumab, is a monoclonal antibody that specifically targets the HER2 protein, which is overexpressed in some breast and gastric malignancies. The injection is given into the bloodstream, and it functions by obstructing HER2 receptors, slowing the growth of cancer cells, and encouraging the immune system to eliminate them. For early-stage or metastatic HER2-positive tumours, it is often administered alone or in conjunction with other cancer therapy. It should only be used under the direction of a trained healthcare practitioner because its use may be linked to potential negative effects.


    Canmab Trastuzumab 440mg Injection characteristics:

    1. HER2 receptors on cancer cells are selectively targeted by the monoclonal antibody Trastuzumab, which is present in Canmab.

    2. High potency: The 440mg of Trastuzumab in the injection enables efficient targeting of HER2-positive cancer cells.

    3. The normal method of administration is an intravenous infusion, which ensures effective transport throughout the body.

    Potential advantages

    1. Canmab is a medication used to treat malignancies that overexpress HER2, including some forms of breast and gastric cancers.

    2. Trastuzumab inhibits the growth and multiplication of cancer cells by blocking the HER2 receptors.

    3. Improved survival rates: Trastuzumab has been shown in clinical trials to increase survival rates and decrease the risk of cancer recurrence in people with HER2-positive breast cancer.

    4. Enhanced response to additional medicines: When used with other cancer treatments, canmab may enhance the response to additional therapies.

    5. Canmab is a targeted therapy that may be less harmful to healthy cells than conventional chemotherapy since it has fewer side effects overall.

    Always speak with an oncologist or other healthcare professional to learn more about the specific advantages and potential hazards of Canmab Trastuzumab 440mg Injection in your particular situation.


    Uses of Canmab Trastuzumab 440mg Injection 

    The primary indication for Canmab Trastuzumab 440mg Injection is the treatment of certain cancers that overexpress the HER2 protein. Its primary indications are HER2-positive metastatic gastric or gastroesophageal junction adenocarcinoma and HER2-positive breast cancer. The specific applications of Canmab Trastuzumab 440mg Injection are as follows:

    1. HER2-Positive Breast Cancer: Canmab is used as a stand-alone therapy or in conjunction with other chemotherapeutic drugs to treat early-stage HER2-positive breast cancer. It can be used as a neoadjuvant or adjuvant treatment (before or after surgery) to shrink tumours, minimise the chance of recurrence, and increase overall survival.

    2. HER2-Positive Metastatic Breast Cancer: Canmab is used in conjunction with other targeted therapies or chemotherapeutic drugs for patients with advanced or metastatic HER2-positive breast cancer to delay the disease's progression, relieve symptoms, and improve quality of life.

    3. Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma with HER2-Positive Status: Canmab is used to treat HER2-positive metastatic gastric or gastroesophageal junction adenocarcinoma. It seeks to reduce disease-related symptoms, increase survival rates, and inhibit the growth of cancer.

    An experienced oncologist should carefully evaluate the patient's exact cancer type, stage, general health, and individual treatment plan before prescribing Canmab Trastuzumab 440mg Injection. Understanding the potential advantages and disadvantages of the medicine is crucial, just like with any medical procedure. 


    What Are the Possible Side-effects of Canmab Trastuzumab 440mg Injection?

    Some Side Effects May Occur During the Injection. Speak Your Doctor Right Away if You Feel Dizzy, Nauseated, Light-headed, Weak, Short of Breath, or if You Have a Headache, Fever, Chills, Sudden Chest Pain, Wheezing, Dry Cough, Hives, or Swelling of Your Face, Lips, Tongue, or Throat.

    Get Emergency Medical Help if You Have Signs of an Allergic Reaction: Hives; Difficult Breathing; Swelling of Your Face, Lips, Tongue, or Throat.

    This Is Not a Complete List of All Side Effects That May Occur. If You Have Questions About Side Effects, Contact Your Health Care Provider. Call Your Doctor for Medical Advice About Side Effects.

    Trade Information
    • Delhi, Mumbai
    • Letter of Credit (L/C) Letter of Credit at Sight (Sight L/C) Paypal Western Union Telegraphic Transfer (T/T) Cash in Advance (CID) Cheque Cash Advance (CA)
    • 10000 Per Month
    • 7 Days
    • Per pack 1 vial
    • Australia North America Eastern Europe Middle East Africa Western Europe Central America South America Asia
    • All India
    Related Products

    right arrow
    left arrow
    Contact Us

    507-508, 5th Floor, The Emporio by Kunj, Opposite 4D Square Mall,, Ahmedabad, Gujarat, 382424, India
    Phone :+918045812292